Why the study?
Is intravenous dipyridamole-thallium imaging safe for the evaluation of coronary artery disease?
Population
3,911 patients evaluated for coronary artery disease
Design
Cohort
Authors
Loading...
May warrant caution with unstable angina or asthma; leaves open need for larger prospective safety data.
Is intravenous dipyridamole-thallium imaging safe for the evaluation of coronary artery disease?
Intravenous dipyridamole-thallium scintigraphy is a relatively safe noninvasive technique for evaluating coronary artery disease, though it carries risks in patients with unstable angina or asthma.
Ranhosky et al. (1990) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: